Abstract. To clarify the mechanism of leptin resistance during pregnancy, we measured plasma leptin concentrations, free to total leptin ratio (percent free leptin) and soluble leptin receptor concentrations in pregnant women, and compared the results with those in non-pregnant women. We collected plasma samples from 23 non-pregnant and 31 pregnant women in the third trimester. Plasma samples from 5 pregnant women were collected longitudinally in each trimester. Plasma leptin concentrations in pregnant women in the second trimester (17.4 ± 3.2 ng/ml) were higher than those in the first trimester of pregnancy (11.0 ± 2.8 ng/ml, n = 5), as previously reported. However, percent free leptin did not change significantly throughout pregnancy. Percent free leptin correlated with total leptin concentrations (ng/ml) in non-pregnant women (r = 0.727, P<0.0001), but not in women in the third trimester of pregnancy (r = 0.006). Constant percent free leptin during pregnancy despite increased leptin concentrations indicates increased leptin binding capacity in pregnant women, that might partly contribute to the establishment of leptin resistance. On the other hand, soluble leptin receptor concentrations showed significant negative correlation with BMI and plasma leptin concentrations in pregnant women (r = -0.470, P<0.01 and r = -0.493, P<0.01, respectively) but not in non-pregnant women. These data suggest the possibility that soluble leptin receptor is a minor component of leptin binding capacity in the plasma of pregnant women.
ENERGY requirement increases in pregnancy to support the growing fetus, and to prepare the mother for nursing thereafter [1, 2] . As energy intake increases, the glucose metabolism alters with hyperlipidemia usually observed in pregnant women. Leptin is a peptide hormone that suppresses food intake and works as a local mediator for glucose and lipid metabolism [3, 4] . It is abundantly produced by adipose tissue, leading to elevated plasma leptin concentrations in obese persons [5] . As a result, plasma leptin concentrations are well correlated with body fat mass and with body mass index (BMI) [6, 7] . However, appetite is not suppressed in obese persons, hence leptin resistance in such persons has been proposed.
We previously reported that leptin is also produced by placental trophoblasts and secreted into both maternal and fetal circulations, leading to increased maternal plasma leptin concentrations during pregnancy [8, 9] . Linnemann et al. reported that 98.4% of placental leptin is secreted into maternal circulation and 1.6% into the fetal circulation [10] . This is in accordance with our report that leptin levels in maternal peripheral veins were significantly higher than those in both umbilical arteries and veins [9] . Maternal plasma leptin concentrations rise 2-to 3-fold during pregnancy and rapidly decline after removal of the placenta, suggesting that the placenta is the major contributor to hyper-leptinemia during pregnancy.
In order to understand the biological roles of leptin as a regulator of energy metabolism during gestation, it is important to clarify the mechanism for leptin resistance in pregnant women. It is reported that leptin binds to some circulating proteins, which may alter its bioactivity, transport and/or clearance [11, 12] . Free leptin is considered biologically active because bound leptin does not reach the hypothalamus, the main site of leptin function. In obese persons, however, leptin binding protein is not likely a major factor of leptin resistance, since the free leptin to total leptin ratio is increased [11, 12] . On the other hand, the role of leptin binding protein in the plasma of pregnant women has yet to be clarified.
The present study was designed to elucidate the mechanism of leptin resistance during pregnancy. To determine the availability of leptin to its center of action in the hypothalamus, we measured percent free leptin in the maternal plasma using both cross sectional and longitudinal studies. Soluble leptin receptor is considered to be one of the key leptin binding proteins in humans and rodents. In mice the soluble leptin receptor is secreted by the placenta, resulting in marked rise of plasma leptin concentrations and thus contributing to the establishment of leptin resistance during pregnancy [13] . In addition to soluble leptin receptor, several leptin binding proteins have been identified, such as the protease inhibitor a2-macroglobulin in human plasma [14] , OB-BP1/Siglec-6, OB-BP2/Siglec-5, and CDC33/Siglec-3, which are the sialic-acid binding lectins of the immunoglobulin superfamily [15] . However, the characteristics of leptin binding proteins have yet to be fully clarified. Therefore, we also examined the circulating soluble leptin receptor concentrations in non-pregnant and pregnant women.
Subjects and Methods

Subjects
Twenty-three non-pregnant women and 31 pregnant women were included in the study. None of these women had diabetes mellitus, hypertension, preeclampsia or any other neuroendocrine diseases before or during pregnancy. Informed consent was obtained from each participant before enrolling in the study. The study was approved by the ethical committee on human research of Kyoto University Graduate School of Medicine.
Plasma samples were collected from 31 pregnant women in the third trimester (35-37 weeks) of gestation. Plasma samples obtained from 23 non-pregnant women were used as control. Clinical data of these patients are summarized in Table 1 . For 5 women (mean age 31.2 ± 10 years) among the 31 pregnant women, plasma samples were also collected in the first (8-12 weeks gestation) and second trimester (28-32 weeks gestation). Body weights of the 5 women before pregnancy and at each trimester were 48.2 ± 2.0, 48.9 ± 2.5, 54.5 ± 1.6 and 56.7 ± 2.1 kg respectively. Their BMI were 19.1 ± 0.6, 19.4 ± 0.8, 21.7 ± 0.5 and 22.3 ± 0.6 kg/m 2 , respectively.
Plasma sampling
Blood samples were drawn from the antecubital vein and were transferred immediately to chilled siliconized glass tubes containing sodium ethylenediamine-tetraacetatic acid (Na 2 EDTA) (1 mg/ml) and aprotinin (1,000 units/ml), and centrifuged at 3,000 × g for 5 min at 4°C. Plasma samples thus obtained were stored at -20°C until use. Values are mean ± SEM (range)
Determination of plasma leptin concentrations
Human leptin concentrations in plasma samples were determined by radioimmunoassay (RIA) for human leptin as previously reported [8, 9, 16] . The detection limit of this assay was 0.05 ng/tube. Inter-and intra-assay variations were 5.9% and 5.3%, respectively [16] .
Separation of free and bound leptin
To separate free leptin from bound leptin, we fractionated plasma samples (200 ml) on Sephacryl S-200 gel filtration column with phosphate buffered saline (PBS), containing 0.01% sodium azide (NaN 3 ). The elution position of the void volume and free leptin was determined by loading blue dextran and recombinant leptin, respectively. Leptin concentration in each fraction was determined by RIA [16] or high sensitivity ELISA (Shionogi Pharmaceutical Co., Osaka, Japan) according to manufacturer's recommendation [17] . Because leptin concentrations in fractionated samples were too low to be measured by RIA, each fraction (500 ml) was freeze-dried and reconstituted with 125 ml of RIA buffer before assay.
We also employed an alternative method to calculate the leptin binding capacity in the plasma as previously reported [18] with slight modification. We incubated plasma with 125 I labeled leptin (~5,000 cpm, specific activity was 0.11 mCi/mg leptin) overnight before fractionation with Sephacryl S-200 gel filtration column. Radioactivity of each fraction was counted after gel filtration.
Determination of soluble leptin receptor concentrations
Soluble leptin receptor concentrations were measured using a commercially available human leptin receptor ELISA kit according to the manufacturer's recommendation (BioVendor Laboratory Medicine Inc., Brno, Czech Republic).
Statistical analysis
Plasma leptin concentrations were distributed log normal. Differences between groups were evaluated by Student's t-test or analysis of variance (ANOVA) with Fisher's least significance difference tests where applicable. Correlations were calculated by Pearson's correlation test. All values were expressed as the mean ± SEM. P values less than 0.05 were regarded as significant.
Results
Fig . 1A shows a representative elution pattern from gel filtration with subsequent RIA. The elution pattern has three peaks; the first is around the void volume (Vo), and the third is at the elution position of recombinant leptin (Re). When determined by ELISA, we also found three peaks in the profile of the same eluate. Elution profile of the radioactivity of the same plasma sample after pre-incubation with 125 I-leptin also has three peaks (Fig. 1B) ; a fourth peak for degraded free 125 I is not shown. The relationship between the first and second peaks remained constant throughout pregnancy in the samples obtained from same patients at different stages of pregnancy. The first 2 peaks were considered as bound leptin and the third, as free leptin. Percent free leptin (%) was calculated by dividing the leptin content or radioactivity eluted in the third peak (free leptin) by radioactivity in all three peaks. Both methods exhibited similar elution patterns, and the calculated free-to-total leptin ratio (percent free leptin) obtained by different methods were almost the same (n = 4). Therefore, in the following study, we employed gel filtration of plasma samples after preincubation with 125 I-leptin.
Plasma leptin concentrations in pregnant women in the second trimester (17.4 ± 3.2 ng/ml, n = 5) were higher than those in the first trimester (11.0 ± 2.8 ng/ ml, n = 5), and remained high in the third trimester ( Fig. 2A) , as previously reported. However, there was no significant change in the percent free leptin after gel filtration in the first, second and third trimesters (Fig.  2B) .
The relationship between percent free leptin and total leptin concentrations or BMI was analyzed in 31 pregnant women in the third trimester. Interestingly, there was no correlation between percent free leptin (%) and total leptin concentrations (ng/ml) (r = 0.006, n = 31, Fig. 3A) or BMI in the third trimester of pregnancy (r = 0.066, n = 31, data not shown). Percent free leptin was virtually constant regardless of varying total leptin concentration or BMI. By contrast, in nonpregnant women, percent free leptin showed a relatively high correlation with total leptin concentration (r = 0.727, P<0.0001, n = 23, Fig. 3B ). Percent free leptin in non-pregnant women also correlated with BMI (r = 0.623, P<0.001, n = 23, data not shown).
Soluble leptin receptor concentrations increased significantly in the second trimester (45.1 ± 3.2 U/ml, n = 5) as compared to those in the first trimester (23.1 ± 4.3 U/m, n = 5), remaining high in the third trimester (33.6 ± 5.4 U/ml, n = 5, Fig. 4) . Soluble leptin 
Discussion
The present study confirmed our previous finding and that of others that plasma leptin concentrations increase significantly during pregnancy [8, 19] . The physiological significance of elevated plasma leptin concentrations during pregnancy is not well understood. The primary role of leptin is a feedback signal to the satiety center. However, such an activity is not beneficial for pregnant women, since they require more nutrients than non-pregnant women do, in order to feed the rapidly growing fetus. In fact, the appetite of pregnant women is not suppressed during pregnancy, suggesting the presence of resistance to the satiety effect of leptin. Another major activity of leptin is to increase insulin sensitivity in peripheral tissues such as muscle, liver, and adipose tissue, and thus leptin stim- ulates energy utilization in these peripheral tissues [20] . The rapidly growing fetus can be regarded as one of the peripheral tissues since it is solely dependent on the energy supply from the mother. If pregnant women responded to the satiety effect of elevated leptin concentration, the energy supply to the fetus would be drastically attenuated [2] . Elevated maternal leptin concentrations during pregnancy may be beneficial for energy mobilization, and therefore for intrauterine fetal nutrition. Our elution profile of plasma leptin using Sephacryl S-200 showed 3 apparent peaks in agreement with Lewandowski et al. using Sephadex G-200 [21] . In previous reports, other investigators have demonstrated 2 peaks (bound and free leptin) [12, 15, 22] . These differences are probably due to the larger pore size of gel particles (Sephadex G-200 or Sephacryl S-200) used to separate the larger sized proteins as compared to Sephadex G-100 gel filtration column used in the previous [12, 15, 22] . Gel filtration profiles with 6M guanidine HCl was almost identical to that without pretreatment (data not shown). At least 2 kinds of leptin binding proteins (240 and 176 kDa) have been detected in ligand blotting and immunoblotting [11] . Gel particles with large pore size might separate two different binding proteins into different peaks. Although the entire picture of leptin binding protein including its source has yet to be known, the a2-macroglobulins, OB-BP1 and OB-BP2, were reported to bind to serum leptin [14, 15] . In mice, placenta secretes leptin binding proteins [13] . However, in humans, cultured placental tissue did not secrete leptin binding protein [18] . Further characterization of leptin binding protein in pregnancy is now under investigation in our laboratory.
In the present study, we did not find any significant change in percent free leptin during pregnancy. Several investigators have attempted to examine free and bound leptin levels during pregnancy. Lewandowski et al. [21] attributed the rise in maternal leptin concentrations between 20-30 weeks to the rise in the bound fraction. Widjaja et al. [22] also reported an increase in bound leptin in the third trimester, whereas Teppa et al. [23] reported an increase in free leptin at term. Although these authors did not calculate free leptin to total leptin ratio in their reports, these findings together suggest that free and bound leptin fractions increase proportionally during pregnancy, with no change of percent free leptin during pregnancy.
In the present study, cross sectional study of pregnant women in the third trimester showed that percent free leptin did not correlate with plasma total leptin concentrations, while in non-pregnant women a significant correlation (r = 0.727, P<0.0001) was observed which is compatible with previous reports [11, 12] . These findings indicate that pregnant women with elevated leptin concentrations have increased leptin binding capacity in their plasma. In contrast, in non- pregnant women, percent free leptin increased as total leptin concentration increased. This suggests that leptin binding capacity is not increased in non-pregnant obese persons and conversely that leptin resistance in the non-pregnant obese person is associated with increased concentration of free leptin. On the other hand, it is possible that increased leptin binding capacity may contribute to the development of the leptin resistance in pregnant women. Thus, the present study suggests that the mechanism for leptin resistance in pregnant women may be different from that in nonpregnant obese women. Since soluble leptin receptor has binding affinity for leptin, it may function as a leptin binding protein in human circulation. In mice, placenta secretes large amounts of soluble leptin receptor into maternal circulation, which binds to leptin and inhibits leptin clearance from plasma [13] . Thus, in mice, plasma leptin levels increase 20-fold during pregnancy. In the present study, soluble leptin receptor concentrations in pregnant women in the second trimester were higher than those in the first trimester and remained high in the third trimester. The major part of soluble leptin receptor was eluted in the 1st peak of gel filtration (data not shown). However, the increase in soluble leptin receptor during human pregnancy was not so drastic as compared to that in murine pregnancy. To identify the various binding proteins in pregnancy will be the subject of further studies. It may be related to our preliminary finding that in primary culture, human placental tissue does not secrete soluble leptin receptor (Yura S and Sagawa N; unpublished finding). Soluble leptin receptor concentration in pregnant women in the third trimester of gestation showed a negative correlation with total plasma leptin concentrations and BMI, while no significant correlation was observed in nonpregnant women. This is in contrast with the fact that the concentration of total leptin binding proteins paralleled with that of total leptin, thus maintaining the percent free leptin at a constant level during pregnancy. These findings together suggest that the soluble leptin receptor accounts for a minor portion of the leptin binding capacity in the plasma of third trimester pregnant women, and that some binding proteins other than soluble leptin receptor may play a major role in the increase in leptin binding capacity during human pregnancy. It is also suggested that these binding proteins are regulated by mechanisms different from that for soluble leptin receptor, although further experiments are necessary to confirm these possibilities.
In summary, the present study demonstrated for the first time a constant free-to-total leptin ratio in spite of the increased leptin concentrations with progression of human pregnancy. Thus, percent free leptin was not high in pregnant women with high leptin concentration in late pregnancy. Soluble leptin receptor concentrations also increased during the course of pregnancy, although they did not correlate with total leptin concentrations in the plasma of pregnant women. These findings suggest the possibility that the increased leptin binding capacity other than soluble leptin receptor might contribute to the establishment of leptin resistance during pregnancy.
